Journal
JOURNAL OF PINEAL RESEARCH
Volume 46, Issue 3, Pages 262-267Publisher
WILEY
DOI: 10.1111/j.1600-079X.2008.00656.x
Keywords
aging; cell cycle; neurodegeneration; p53
Categories
Funding
- Spain's Ministerio de Educacion y Ciencia [BFU/2006-11981, SAF2005-01604, SAF2006-13092]
- Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [PI080400]
- Autonomous Government of Catalonia [2005/SGR00893]
- Fundacio La Marato [063230]
Ask authors/readers for more resources
The neuroprotective effects of melatonin in an experimental model of aging-induced apoptosis have been examined. Cerebellar granule neurons show characteristics of apoptosis after 17 days in culture (DV). The addition of melatonin to neuronal cell cultures (100-500 mu m) resulted in neuroprotective and antiapoptotic effects, which were revealed by nuclear condensed cell counting. In a thorough analysis by Western-blot of the potential pathways responsible for melatonin's neuroprotective effects, we found an increase in the activation of prosurvival Akt. Subsequently GSK3 beta inhibition and an increase in p-FOXO1 phosphorylation occurred. In this model of aging, apoptosis was associated with an elevated DNA damage, as demonstrated by an increase in the activation of ataxia telangiectasia muted (ATM). Subsequently, downstream targets such as p53 were activated. Furthermore, the process of DNA damage was coupled to an increase in the expression of certain proteins involved in cell cycle regulation; these were cyclin D and the proapoptotic transcription factor E2F-1. We conclude that the antiapoptotic effects of melatonin were mediated by two potential mechanisms: by increasing the activity of prosurvival pathways via Akt and by the prevention of DNA damage (via ATM inhibition) followed by the reduction of cell cycle re-entry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available